The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 16, 2021
Filed:
Nov. 02, 2016
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Petrus Jacobus Johannes Antonius Buijnsters, Etten-Leur, NL;
Henricus Jacobus Maria Gijsen, Breda, NL;
Wilhelmus Helena Ignatius Maria Drinkenburg, Molenschot, NL;
Abdallah Ahnaou, Sint-Lambrechts-Woluwe, BE;
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61P 25/34 (2006.01); A61P 25/36 (2006.01); A61P 25/28 (2006.01); A61P 25/22 (2006.01); A61P 25/32 (2006.01); A61P 25/18 (2006.01); A61P 25/16 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/28 (2018.01); A61P 25/32 (2018.01); A61P 25/34 (2018.01); A61P 25/36 (2018.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present invention relates to a novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.